Dana Investment Advisors, Inc. Moderna, Inc. Transaction History

Dana Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $876,579 - $1.44 Million	-8,661 Reduced 75.65%	2,788 $331,000
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $11,695 - $15,815	137 Added 1.21%	11,449 $1.22 Million
Q4 2023 Feb 07, 2024	BUY	$69.51 - $104.43 $518,058 - $778,316	7,453 Added 193.13%	11,312 $1.12 Million
Q3 2023 Nov 15, 2023	BUY	$96.41 - $126.61 $73,464 - $96,476	762 Added 24.6%	3,859 $398,000
Q2 2023 Aug 15, 2023	BUY	$118.5 - $160.53 $366,994 - $497,161	3,097 New	3,097 $376,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.